Yüklüyor......
The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report
BACKGROUND: So far there has been little evidence on the antithrombotic treatment of patients presenting with atrial fibrillation (AF) and a CHA(2)DS(2)-VASc score of 1 in men (2 in women). However, a recently published position paper suggests a personalized approach in weighing individual risk fact...
Kaydedildi:
| Yayımlandı: | Eur Heart J Case Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649479/ https://ncbi.nlm.nih.gov/pubmed/33204971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/ytaa176 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|